Imprimis Pharma (IMMY) Reports Q2 Loss of $0.35/Share

August 15, 2016 5:17 PM EDT
Get Alerts IMMY Hot Sheet
Trade IMMY Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Imprimis Pharma (NASDAQ: IMMY) reported Q2 EPS of ($0.35), versus ($0.39) reported last year. Revenue for the quarter came in at $4.9 million, versus $1.97 million reported last year.

For earnings history and earnings-related data on Imprimis Pharma (IMMY) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment